Evidence map›Paper›PMID 30397674›Full record

ArticleJournal of preventive medicine and hygiene2018

Do Tuscan people adhere to meningococcal C vaccination during an emergency campaign?

A Bechini, D Paolini, F Pieralli, L Baggiani, G Mereu, M G Santini, T Brocca, S Gostinicchi, E Gori, S Boccalini and 2 more

Open access · greenAbstract read
In one paragraph

Article in Journal of preventive medicine and hygiene, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
0.2field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 3 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. [Journal of preventive medicine and hygiene · 2021
    Article
  4. [Health Technology Assessment of meningococcal B vaccine (TrumenbaJournal of preventive medicine and hygiene · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

A BechiniDepartment of Health Sciences, University of Florence, Florence, Italy.
D PaoliniMedical School of Hygiene and Preventive Medicine, Department of Health Sciences, University of Florence, Italy.
F PieralliDepartment of Health Sciences, University of Florence, Florence, Italy.
L BaggianiCentral Tuscany LHU, Florence, Italy.
G MereuCentral Tuscany LHU, Florence, Italy.
M G SantiniCentral Tuscany LHU, Florence, Italy.
T BroccaCentral Tuscany LHU, Florence, Italy.
S GostinicchiCentral Tuscany LHU, Florence, Italy.
E GoriCentral Tuscany LHU, Florence, Italy.
S BoccaliniDepartment of Health Sciences, University of Florence, Florence, Italy.
P BonanniDepartment of Health Sciences, University of Florence, Florence, Italy.
G BonaccorsiDepartment of Health Sciences, University of Florence, Florence, Italy.
University of Florence · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTuscany region (Italy) recorded a rise in the number of meningococcal disease cases between January 2015 and February 2016, (52 cases) compared to 2014 (16 cases). The aim of this study was to describe the emergency meningococcal C (MenC) vaccination programme in Tuscany and the population's adherence to the activities performed in the Local Health Unit (LHU) of Florence.

methodsThe MenC vaccination programme and the planning of the prevention and communication activities were analysed in the LHU of Florence. As an indicator of population's adherence, the vaccination coverage (VC) during the emergency campaign was investigated and adverse drug reactions (ADR) surveillance was reported.

resultsThe communication campaign included a dedicated toll-free telephone number, press releases (newspapers, radio, television, websites), and informative letters addressed to mayors, secondary schools, and sports associations. Citizens aged 11-20 years were the primary target of the campaign. Due to the high incidence of cases among older people, the vaccination was extended to subjects over 45 years. The population's adherence to the vaccination campaign was satisfactory: VC reached 47.1% for the primary target. The ADR reporting rate (3.1/10,000) on meningococcal vaccine in our study confirmed the safety of the vaccination.

conclusionsIn 2017, only 10 cases of invasive meningococcal diseases (IMD) were reported, suggesting the effectiveness of the immunization campaign. Similar VC during emergency MenC vaccination programmes have been reached in other Italian regions and other EU countries, too. The achievement of greater vaccination coverage is restricted by a sentiment of hesitancy towards vaccines among the general population.

Indexed as

Immunization ProgramsMedication AdherenceAdolescentAdultChildDisease OutbreaksEmergency Medical ServicesHumansItalyMeningococcal VaccinesMiddle AgedPopulation SurveillanceYoung AdultMeningococcal Vaccinesserogroup C meningococcal conjugate vaccineEmergency immunization campaignMeningococcal C invasive diseasePopulation adherenceTuscanyVaccination coverage

Identifiers

PMID30397674
PMCPMC6196373
OpenAlexW2900582737

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.